INNT Shares Outstanding History

Below is a table of the INNT shares outstanding history going back to 2/1/2018:

Date INNT Shares Outstanding

Also see: INNT Market Cap History
INNT Historical Shares Outstanding:
+494.83% CAGR
INNT Historical Shares Outstanding: +494.83% CAGR

Mouse over chart for data details
2/1/2018 ...3/17/2020
Innovate Biopharmaceuticals a clinical-stage biopharmaceutical company developing medicines for autoimmune and inflammatory diseases. Co.'s pipeline includes drug candidates for celiac disease, nonalcoholic steatohepatitis (NASH), alcoholic steatohepatitis, Crohn's disease and ulcerative colitis (UC). Co.'s key program, INN-202 (larazotide acetate or larazotide) is entering Phase 3 registration trials for celiac disease. Co. is also developing larazotide for the treatment of NASH (INN-217), a smaller subset of liver disease stemming from the fatty liver disease. INN-108 is an oral small molecule therapeutic for UC. Co. owns the global rights to INN-329, a key formulation of secretin. We show 10 historical shares outstanding datapoints in our coverage of INNT's shares outstanding history.

Understanding the changing numbers of INNT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like INNT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching INNT by allowing them to research INNT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree INNT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Innovate Biopharmaceuticals (INNT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

INNV Shares Outstanding History
INO Shares Outstanding History
INSM Shares Outstanding History
INSP Shares Outstanding History
INSY Shares Outstanding History
INTS Shares Outstanding History
INVA Shares Outstanding History
INVO Shares Outstanding History
INZY Shares Outstanding History
IOBT Shares Outstanding History
More Healthcare companies »


INNT Shares Outstanding History | | Copyright © 2017 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.